| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| romiplostim | aryl hydrocarbon receptor | NA | Successful target | TTD , DGIDB | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Thrombocytopenia[MeSHID:D013921] |
0.27 | approved | unknown |
| romiplostim | fibroblast growth factor receptor 1 | NA | Successful target | TTD , DGIDB | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Thrombocytopenia[MeSHID:D013921] |
0.09 | approved | unknown |
| romiplostim | vegfr1 messenger rna | NA | Successful target | TTD | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Thrombocytopenia[MeSHID:D013921] |
NA | approved | unknown |
| romiplostim | vascular endothelial growth factor receptor 2 | NA | Successful target | TTD , DGIDB | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Thrombocytopenia[MeSHID:D013921] |
0.06 | approved | unknown |
| romiplostim | tyrosine-protein kinase kit | NA | Successful target | TTD , DGIDB | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Thrombocytopenia[MeSHID:D013921] |
0.11 | approved | unknown |
| romiplostim | thrombopoietin receptor | biotech | Successful target | TTD , drugbank , DGIDB | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Thrombocytopenia[MeSHID:D013921] |
4.34 | approved | agonist |
| romiplostim | platelet-derived growth factor receptor alpha | NA | Successful target | TTD , DGIDB | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Thrombocytopenia[MeSHID:D013921] |
0.12 | approved | unknown |
| romiplostim | platelet-derived growth factor receptor beta | NA | Successful target | TTD , DGIDB | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Thrombocytopenia[MeSHID:D013921] |
0.1 | approved | unknown |
| romiplostim | proto-oncogene c-ret | NA | Successful target | TTD , DGIDB | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Thrombocytopenia[MeSHID:D013921] |
0.12 | approved | unknown |
| click here to return to the previous page | ||||||||